Genes that Regulate Metastasis and Angiogenesis

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Neuro-Oncology

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1006466605356PMID 11245283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of vascular endothelial growth factor in pathological angiogenesis

  2004cited by this paper
• Cytokines in tumour growth, migration and metastasis

  2004cited by this paper
• The diagnostic and prognostic value of tumor angiogenesis.

  2003cited by this paper
• Animal models for Ras-induced metastasis.

  2001cited by this paper
• CD44 Interaction with Tiam1 Promotes Rac1 Signaling and Hyaluronic Acid-mediated Breast Tumor Cell Migration*

  2000cited by this paper
• Hepatocyte growth factor, Met, and CD44. Amenage a trois in B cells

  2000cited by this paper
• Openings between defective endothelial cells explain tumor vessel leakiness.

  2000cited by this paper
• The multiple roles of PTEN in tumor suppression.

  2000cited by this paper
• Regulation of angiogenesis via vascular endothelial growth factor receptors.

  2000cited by this paper
• Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

  2000cited by this paper
• The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.

  2000cited by this paper
• Clinical targets for anti-metastasis therapy.

  2000cited by this paper
• Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.

  2000cited by this paper
• Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator.

  1999cited by this paper
• Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types

  1999cited by this paper
• Rho GTPases Control Polarity, Protrusion, and Adhesion during Cell Movement

  1999cited by this paper
• Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors.

  1999cited by this paper
• Biological implications of macrophage infiltration in human tumor angiogenesis

  1999cited by this paper
• Regulation of matrix metalloproteinase‐2 (MMP‐2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP‐2 expression and activation accompanying up‐regulation of membrane type‐1 MMP

  1999cited by this paper
• Matrix metalloproteinases in tumour invasion and metastasis

  1999cited by this paper
• Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis.

  1999cited by this paper
• Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.

  1999cited by this paper
• Fibroblast Growth Factors in Tumor Progression and Angiogenesis

  1999cited by this paper
• Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions.

  1999cited by this paper
• The angiopoietins: Yin and Yang in angiogenesis.

  1999cited by this paper
• The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene.

  1999cited by this paper
• Molecular mechanisms of tumor metastasis and angiogenesis

  1999cited by this paper
• The diversity of T‐cell co‐stimulation in the induction of antitumor immunity

  1999cited by this paper
• Antiangiogenic agents.

  1999cited by this paper
• Retrovirus producer cells encoding antisense VEGF prolong survival of rats with intracranial GS9L gliomas

  1999cited by this paper
• Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration.

  1999cited by this paper
• Thrombospondin-1, PECAM-1, and regulation of angiogenesis.

  1999cited by this paper
• Expression of the proteolytic factors, tPA and uPA, PAI‐1 and VEGF during malignant glioma progression

  1999cited by this paper
• The clinical manipulation of angiogenesis: pathology, side‐effects, surprises, and opportunities with novel human therapies

  1999cited by this paper
• The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells

  1999cited by this paper
• Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells.

  1999cited by this paper
• Fibronectin and its integrin receptors in cancer.

  1999cited by this paper
• Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas

  1999cited by this paper
• Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.

  1999cited by this paper
• Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

  1999cited by this paper
• Small molecule inhibitors of tumor-promoted angiogenesis, including protein tyrosine kinase inhibitors.

  1999cited by this paper
• Angiogenesis: how a tumor adapts to hypoxia.

  1999cited by this paper
• Matrix metalloproteinases and metastasis

  1999cited by this paper
• The clinical manipulation of angiogenesis: pathology, side‐effects, surprises, and opportunities with novel human therapies

  1999cited by this paper
• Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).

  1999cited by this paper
• Integrin signaling.

  1999cited by this paper
• Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase.

  1999cited by this paper
• Dominant role of E-cadherin in the progression of bladder cancer.

  1999cited by this paper
• Rho-like GTPases: their role in cell adhesion and invasion.

  1999cited by this paper
• Growth factor signaling pathways in vascular development

  1999cited by this paper
• The role of integrin receptors in aspects of glioma invasion in vitro

  1999cited by this paper
• Urokinase plasminogen activator: A prognostic marker in multiple types of cancer

  1999cited by this paper
• Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.

  1999cited by this paper
• The normal structure and function of CD44 and its role in neoplasia.

  1998cited by this paper
• Autocrine Motility Factor in Pulmonary Adenocarcinomas: Results of an Immunohistochemical Study

  1998cited by this paper
• Functions of the von Hippel–Lindau tumour suppressor protein

  1998cited by this paper
• Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review).

  1998cited by this paper
• Tumor induction of VEGF promoter activity in stromal cells.

  1998cited by this paper
• Stromal angiogenesis in human glioma: a role of platelet-derived endothelial cell growth factor.

  1998cited by this paper
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• Tumor angiogenesis: biology and therapeutic prospects.

  1998cited by this paper
• The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).

  1998cited by this paper
• Focal adhesion kinase and its potential involvement in tumor invasion and metastasis

  1998cited by this paper
• Angiogenesis and tumor metastasis.

  1998cited by this paper
• Metalloproteases and urokinase in angiogenesis and tumor progression.

  1998cited by this paper
• Nm23 and tumour metastasis: basic and translational advances.

  1998cited by this paper
• Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review.

  1998cited by this paper
• Regulation of Proliferation-Survival Decisions during Tumor Cell Hypoxia

  1998cited by this paper
• Fibronectin Fragments Modulate Human Retinal Capillary Cell Proliferation and Migration

  1998cited by this paper
• Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer.

  1998cited by this paper
• Integrins and GTPases in tumour cell growth, motility and invasion.

  1998cited by this paper
• Metalloproteases and urokinase in angiogenesis and tumor progression.

  1998cited by this paper
• The regulation of neovascularization of matrix metalloproteinases and their inhibitors.

  1998cited by this paper
• The mutationally activated Met receptor mediates motility and metastasis.

  1998cited by this paper
• Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

  1998cited by this paper
• Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer.

  1998cited by this paper
• Signaling pathways in Ras-mediated tumorigenicity and metastasis.

  1998cited by this paper
• Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.

  1998cited by this paper
• Production of Urokinase-Type Plasminogen Activator (u-PA) and Plasminogen Activator Inhibitor-1 (PAI-1) in Human Brain Tumours

  1998cited by this paper
• Signaling by integrin receptors

  1998cited by this paper
• Tumor Suppressor PTEN Inhibits Integrin- and Growth Factor–mediated Mitogen-activated Protein (MAP) Kinase Signaling Pathways

  1998cited by this paper
• Cancer metastasis: Biological and clinical aspects

  1998cited by this paper
• Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors.

  1998cited by this paper
• Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In Vitro

  1998cited by this paper
• Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis.

  1998cited by this paper
• Angiogenesis in P‐ and E‐Selectin‐Deficient Mice

  1998cited by this paper
• Response of tumour cells to hypoxia: role of p53 and NFkB.

  1998cited by this paper
• Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy.

  1998cited by this paper
• Tumor-suppressor p53: implications for tumor development and prognosis.

  1998cited by this paper
• Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.

  1998cited by this paper
• Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.

  1998cited by this paper
• Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways.

  1997cited by this paper
• HGF/SF in angiogenesis.

  1997cited by this paper
• Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

  1997cited by this paper
• Matrix Metalloproteinases

  1997cited by this paper
• Mechanisms of angiogenesis

  1997cited by this paper
• Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.

  1997cited by this paper
• The urokinase‐type plasminogen activator system in cancer metastasis: A review

  1997cited by this paper
• Vascular Endothelial Growth Factor Stimulates Tyrosine Phosphorylation and Recruitment to New Focal Adhesions of Focal Adhesion Kinase and Paxillin in Endothelial Cells*

  1997cited by this paper
• The cytoskeleton and brain tumour cell migration.

  1997cited by this paper

• Quantile-specific heritability of serum growth factor concentrations

  2021cites this paper
• Antiproliferative and Antimetastatic Effects of Praeruptorin C on Human Non–Small Cell Lung Cancer through Inactivating ERK/CTSD Signalling Pathways

  2020cites this paper
• Cancer targeted gene therapy for inhibition of melanoma lung metastasis with eIF3i shRNA loaded liposomes.

  2019cites this paper
• Mechanisms of carcinogenesis : from initiation and promotion to the hallmarks

  2019cites this paper
• Metastasis-associated protein 2 regulates human hepatocellular carcinoma metastasis progression through modulating p38MAPK/MMP2 pathways

  2019cites this paper
• 5 Approaches in Gene Therapy of Cancer and Cardiovascular Diseases

  2018cites this paper
• Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and uPA expression

  2018cites this paper
• Rokowanie kliniczne i podstawy terapii przeciwnowotworowej

  2018cites this paper
• Monocyte chemoattractant protein 1 and fractalkine play opposite roles in angiogenesis via recruitment of different macrophage subtypes.

  2018cites this paper
• Immunohistochemical evaluation of tumor angiogenesis and the role of mast cells in oral squamous cell carcinoma

  2018cites this paper
• Licochalcone A inhibits the invasive potential of human glioma cells by targeting the MEK/ERK and ADAM9 signaling pathways.

  2018cites this paper
• Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression

  2017cites this paper
• Invasion and metastasis of tumour cells resistant to chemotherapy.

  2017cites this paper
• 14 – The Molecular Biology of Head and Neck Cancer

  2017cites this paper
• CHAPTER 3 – Overview of Pathology and Treatment of Metastatic Brain Tumors

  2016cites this paper
• CHAPTER 6 – Overview of Pathology and Treatment of Intramedullary Spinal Cord Metastases

  2016cites this paper
• Overview of Pathology and Treatment of Primary Brain Tumors

  2016cites this paper
• Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells

  2016cites this paper
• Casticin Inhibits A375.S2 Human Melanoma Cell Migration/Invasion through Downregulating NF-κB and Matrix Metalloproteinase-2 and -1

  2016cites this paper
• Chapter 3 – Overview of Epidemiology, Pathology, and Treatment of Metastatic Brain Tumors

  2015cites this paper
• MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells.

  2015cites this paper
• Chapter 2 – Overview of Epidemiology, Pathology, and Treatment of Primary Brain Tumors

  2015cites this paper
• Correlation between expressions of hypoxia -inducible factor (HIF-1α), blood vessels density, cell proliferation, and apoptosis intensity in canine fibromas and fibrosarcomas

  2014cites this paper
• Licochalcone A Suppresses Migration and Invasion of Human Hepatocellular Carcinoma Cells through Downregulation of MKK4/JNK via NF-κB Mediated Urokinase Plasminogen Activator Expression

  2014influential citation
• Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression

  2014cites this paper
• Effects of Vietnamese Sophora Root on growth, adhesion, invasion and motility of melanoma cells.

  2013cites this paper
• Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells.

  2013cites this paper
• Wachstumskontrolle und Krebs

  2012cites this paper
• Loss of mitochondrial thioredoxin reductase delays angiogenic switch and impairs tumour growth

  2011cites this paper
• Could nanoparticle systems have a role in the treatment of cerebral gliomas?

  2011cites this paper
• Approaches in Gene Therapy of Cancer and Cardiovascular Diseases

  2011cites this paper
• Magnetic resonance imaging targeting of intracranial glioma xenografts by Resovist-labeled endothelial progenitor cells

  2011cites this paper
• En rolle for MK5 i cellesyklus-progresjon?

  2011cites this paper
• Redefining Disease and Pharmaceutical Targets Through Molecular Definitions and Personalized Medicine

  2010cites this paper
• Prevalence of Allelic Loss at TP53 in Endometrial Carcinomas

  2010influential citation
• Overview of the Molecular Genetics and Molecular Chemotherapy of GBM

  2010cites this paper
• Betydningen av uPAR på cellers evne til migrasjon og invasjon

  2009cites this paper
• Ki-67 and vascular endothelial growth factor expression in intracranial meningiomas in dogs.

  2009cites this paper
• Bevacizumab: Review of Development, Pharmacology, and Application to Brain Tumors

  2009cites this paper
• Systems Biology of Personalized Medicine

  2009cites this paper
• Prediction of Nodal Metastases from Genomic Analyses of the Primary Tumor

  2009cites this paper
• Tumor-Modifying Effect of Cardiogen Peptide on M-1 Sarcoma in Senescent Rats

  2009cites this paper
• Glioblastoma multiforme

  2008cites this paper
• Endothelial Growth Factor in Malignant Glioma Cells Tristetraprolin Down-regulates Interleukin-8 and Vascular

  2008cites this paper
• ESTUDIO MOLECULAR Y CITOGENÉTICO DEL CARCINOMA UROTELIAL: DETECCIÓN TEMPRANA DE LA ENFERMEDAD Y DE SU DISEMINACIÓN

  2008cites this paper
• Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.

  2008cites this paper
• Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.

  2007cites this paper
• Characterization of the Anti-angiogenic Properties of KDR-Ig4-7 and its Variants as Potential Anti-cancer Therapeutics

  2007cites this paper
• Anti-angiogenic gene therapy of cancer: current status and future prospects.

  2007cites this paper
• Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.

  2006cites this paper
• Vasculogenesis and Angiogenesis

  2006cites this paper
• Chemotherapy for Brain Metastases

  2006cites this paper
• Lipocalin 2 Antagonizes the Proangiogenic Action of Ras in Transformed Cells

  2006cites this paper
• Vascular endothelial growth factor expression in canine intracranial meningiomas and association with patient survival.

  2006cites this paper
• Expression of DNA-dependent Protein Kinase and Its Relationship with Epidermal Growth Factor Receptor Signaling in Metastatic Cancer Cell Lines

  2005cites this paper
• Angiogenesis and cerebral neoplasia.

  2005cites this paper
• Analysis of Tumor-Host Interactions by Gene Expression Profiling of Lung Adenocarcinoma Xenografts Identifies Genes Involved in Tumor Formation

  2005cites this paper
• Expression and significance of TGF-beta isoform and VEGF in osteosarcoma.

  2005cites this paper
• Angiogenesis and the role of epigenetics in metastasis

  2004cites this paper
• Metastases to the brain: current management perspectives

  2004cites this paper
• Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis

  2004cites this paper
• Transcriptional regulation of osteopontin and the metastatic phenotype: Evidence for a Ras-activated enhancer in the human OPN promoter

  2004cites this paper
• Expression of VEGF and brain specific angiogenesis inhibitor-1 in glioblastoma: prognostic significance.

  2004cites this paper
• Relationship between Antiapoptotic Molecules and Metastatic Potency and the Involvement of DNA-Dependent Protein Kinase in the Chemosensitization of Metastatic Human Cancer Cells by Epidermal Growth Factor Receptor Blockade

  2004cites this paper
• Application of Proteomics in the Study of Tumor Metastasis

  2004cites this paper
• Heritability of circulating growth factors involved in the angiogenesis in healthy human population.

  2004cites this paper
• Angiogenesis: A Promising Target for Cancer Prevention

  2003cites this paper
• Regulation of angiogenesis by MAP kinase pathways during cardiac ischaemia and reperfusion

  2003cites this paper
• Systemic administration of a recombinant adenovirus encoding a HSA-Angiostatin kringle 1-3 conjugate inhibits MDA-MB-231 tumor growth and metastasis in a transgenic model of spontaneous eye cancer.

  2003cites this paper
• Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node

  2003cites this paper
• Angiogenesis as a new target for cancer control

  2003cites this paper
• CD44 function as a growth factor co-receptor

  2003cites this paper
• Mechanisms in Carcinogenesis and Cancer Prevention

  2003cites this paper
• Advances in molecular therapies in patients with brain tumors.

  2003cites this paper
• Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix.

  2002cites this paper
• Anti-angiogenic agents for the treatment of brain tumors.

  2002influential citation
• Chemotherapy for the treatment of metastatic brain tumors

  2002cites this paper
• Dephosphorylation of endothelial nitric oxide synthase contributes to the anti‐angiogenic effects of endostatin

  2002cites this paper
• Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways

  2001cites this paper